Search

Your search keyword '"Greco, Beatrice"' showing total 154 results

Search Constraints

Start Over You searched for: Author "Greco, Beatrice" Remove constraint Author: "Greco, Beatrice"
154 results on '"Greco, Beatrice"'

Search Results

4. Immunomics-Guided Antigen Discovery for Praziquantel-Induced Vaccination in Urogenital Human Schistosomiasis

5. Expression of inducible factors reprograms CAR-T cells for enhanced function and safety

6. The Pan African Vivax and Ovale Network (PAVON): Refocusing on Plasmodium vivax, ovale and asymptomatic malaria in sub-Saharan Africa

7. Treatment of Canine Leishmaniasis with Meglumine Antimoniate: A Clinical Study of Tolerability and Efficacy.

8. Acute onset of hypertensive encephalopathy in a dog with right adrenal pheochromocytoma and neoplastic invasion of the caudal vena cava: Case report and review of the literature.

9. The Role of Mitochondrial Copy Number in Neurodegenerative Diseases: Present Insights and Future Directions.

13. CAR T cell manufacturing from naive/stem memory T lymphocytes enhances antitumor responses while curtailing cytokine release syndrome

14. 306 N-glycosylation inhibition hinders immunosuppressive tumor microenvironment cells improving CAR T cell efficacy

16. CD4 CAR-T cells targeting CD19 play a key role in exacerbating cytokine release syndrome, while maintaining long-term responses

19. Time 2EVOLVE: predicting efficacy of engineered T-cells – how far is the bench from the bedside?

20. Disrupting N-glycan expression on tumor cells boosts chimeric antigen receptor T cell efficacy against solid malignancies

23. Immunomics-guided discovery of serum and urine antibodies for diagnosing urogenital schistosomiasis: a biomarker identification study

25. Myeloid cell‐based delivery of IFN‐γ reprograms the leukemia microenvironment and induces anti‐tumoral immune responses

28. Immunomics-Guided Antigen Discovery for Praziquantel-Induced Vaccination in Urogenital Human Schistosomiasis

29. Preclinical antimalarial combination studies: the case of M5717, a P. falciparum elongation factor 2 inhibitor and pyronaridine, a hemozoin formation inhibitor

30. Comparison of Two Dosing Regimens of Miltefosine, Both in Combination With Allopurinol, on Clinical and Parasitological Findings of Dogs With Leishmaniosis: A Pilot Study

31. Preclinical Antimalarial Combination Study of M5717, a Plasmodium falciparum Elongation Factor 2 Inhibitor, and Pyronaridine, a Hemozoin Formation Inhibitor

32. PS-003: EVIDENCE-INFORMED POLICY MAKING: CHALLENGES AND OPPORTUNITIES

33. Molecular detection of P. vivax and P. ovale foci of infection in asymptomatic and symptomatic children in Northern Namibia

35. Flexible 3D Cell-Based Platforms for the Discovery and Profiling of Novel Drugs Targeting Plasmodium Hepatic Infection

36. Glucose-6-phosphate dehydrogenase deficiency genotypes and allele frequencies in the Kavango and Zambezi regions of northern Namibia

38. OC 8415 A TRANSLATIONAL PRECLINICAL PLATFORM TO ASSESS THE CHEMOPROPHYLAXIS AND CHEMOPREVENTION DOSE-RELATIONSHIP OF MALARIA DRUGS: THE CASE STUDY OF M5717

43. Neuropeptide Y inhibits estrous behavior and stimulates feeding via separate receptors in Syrian hamsters

46. Characterization of immune cell subsets during the active phase of multiple sclerosis reveals disease and c-Jun N-terminal kinase pathway biomarkers

48. Soluble (s) CD14 and Plasmatic Lipopolysaccharides (LPS) in Patients with Chronic Hepatitis C Before and After Treatment with Interferon (IFN)-α

Catalog

Books, media, physical & digital resources